method
develop
quantit
measur
acth
produc
human
lymphocyt
shown
ph
adjust
essenti
process
precursor
molecul
proopiomelanocortin
pomc
linear
time
incub
acth
product
shown
exist
specif
endopeptidas
lymphocyt
process
pomc
molecul
remain
doubt
long
recogn
cell
direct
particular
protein
differ
intracellular
organel
process
storag
secret
product
without
prolong
storag
cell
function
distinct
basal
secret
stimul
secret
also
appreci
long
time
secretori
tissu
measur
rate
secret
absenc
secretagogu
basal
rate
secretori
rate
increas
substanti
respons
appropri
stimuli
stimul
rate
term
constitut
regul
pathway
wide
use
describ
cellular
entiti
lead
basal
stimul
secret
scheme
newli
synthes
protein
proceed
golgi
apparatu
destin
secretori
granul
date
receiv
june
date
accept
june
sort
away
protein
becom
part
constitut
pathway
constitut
pathway
postul
involv
postgolgi
vesicl
distinct
secretori
granul
clear
intracellular
compart
along
biosynthet
pathway
mani
secretori
cell
acid
gradual
acidif
ci
tran
face
golgi
stack
matur
secretori
granul
even
acid
ph
golgi
compart
evid
cell
immun
system
synthes
hormon
classic
associ
neuroendocrin
system
obtain
observ
product
interferon
ifna
human
peripher
leukocyt
coordin
express
peptid
antigenit
relat
corticotropin
acth
acth
bioactiv
human
leukocyt
ifna
prepar
demonstr
pepsin
acid
treatment
acth
deriv
human
leukocyt
ifno
pepsin
digest
comigr
purifi
acth
standard
gel
electrophoresi
peripher
leukocyt
secret
acth
proopiomelanocortin
pomc
deriv
peptid
presenc
applic
neurochem
stimuli
immunoreact
acth
iracth
identifi
human
peripher
leukocyt
virusinfect
endotoxin
treatment
found
similar
pituitaryderiv
acth
respect
biolog
activ
molecular
weight
antigen
retent
time
revers
phase
high
pressur
liquid
chromatographi
column
iracth
also
possess
remark
steroidogen
activ
inject
hypophysectom
mice
absenc
neurochem
stimuli
human
peripher
leukocyt
synthes
littl
acth
cultur
incub
medium
almost
devoid
iracth
previous
leukocytederiv
acth
measur
mous
adren
tumor
yl
cell
round
assay
cell
round
proport
amount
acth
present
assay
could
detect
unit
osng
acth
studi
method
develop
quantit
measur
acth
produc
human
lymphocyt
prepar
pure
lymphocyt
suspens
method
boyum
use
minor
modif
blood
drawn
liheparin
sigma
contain
polypropylen
syring
usp
liheparinloml
blood
dilut
steril
filter
phosphat
buffer
salin
pb
ph
well
mix
layer
onto
lymphoprep
nyegaard
co
oslo
norway
densiti
f
gml
c
ml
tube
tube
centrifug
min
beckman
centrifug
mononuclear
cell
interphas
aspir
dilut
equal
volum
pb
contain
vv
foetal
calf
serum
fc
gibco
limit
paisley
scotland
suspens
centrifug
min
superiniti
measur
medium
contain
lymphocyt
show
absenc
acth
observ
deduc
acth
produc
lymphocyt
still
integr
part
precursor
molecul
pomc
method
evalu
wherebi
acth
could
releas
pomc
molecul
initi
cultur
period
lymphocyt
cultur
treat
mv
pepsin
ph
adjust
optim
condit
pepsin
tabl
clear
step
necessari
releas
acth
precursormolecul
sinc
pepsintr
cultur
show
statist
signific
increas
acth
level
p
mannwhitney
u
test
investig
possibl
ph
alon
natant
aspir
pellet
resuspend
vv
fcspb
centrifug
mitt
step
repeat
pellet
resuspend
vv
medium
gibco
limit
paisley
scotland
ph
contain
vv
antibiot
novopen
uml
novostrep
uml
dissolv
ml
steril
distil
water
cell
suspens
transfer
petri
dish
incub
hotpack
cozincub
min
co
humid
supernat
aspir
concentr
lymphocyt
determin
coultercount
aliquot
lymphocyt
suspens
x
cell
incub
lml
incub
medium
vv
ph
antibiot
cozincub
co
humid
synthesi
pomc
termin
adjust
ph
process
pomc
carri
hour
releas
acth
subsequ
measur
quantit
use
standard
acth
irma
adrenocorticotropinhormon
kit
eurodiagnost
bv
apeldoorn
holland
sensit
assay
judg
sd
chang
duplic
standard
zero
valu
interand
intraassay
variabl
less
mention
kit
highli
specif
acth
fragment
interfer
assay
aliquot
suspens
contain
x
cellsml
also
incub
differ
time
ph
adjust
figur
linear
acth
product
time
incub
clear
addit
found
acth
product
increas
linearli
increas
concentr
lymphocyt
fig
lymphocyt
male
control
mean
age
sd
k
display
acth
level
f
hour
femal
control
mean
age
k
sd
f
show
level
hour
statist
signific
differ
two
sex
could
detect
tabl
mannwhitney
utest
initi
acth
measur
lymphocyt
cultur
reveal
absenc
neuropeptid
medium
cultur
treat
pepsin
pepsin
treatment
phoptimum
pepsin
howev
caus
releas
acth
precursor
molecul
pomc
abovement
find
agreement
previou
investig
pituitari
cell
found
basal
secret
neuropeptid
enrich
precursor
molecul
stimul
secret
enrich
product
peptid
subsequ
investig
reveal
adjust
alon
suffici
produc
acth
quantifi
amount
could
result
stimul
specif
endopeptidas
involv
process
pomcmolecul
similar
found
pituitari
cell
although
phoptima
two
specif
endopeptidas
isol
pituitari
cell
respect
still
uncertain
endopeptidas
involv
process
pomc
human
lymphocyt
incub
lymphocyt
cultur
medium
specif
time
period
follow
ph
adjust
describ
reveal
linear
time
incub
basal
measur
acth
shown
smith
blalock
lymphocyt
although
unstimul
factor
like
crf
vasopressin
mitogen
continu
synthes
acth
form
precursor
molecul
agreement
result
observ
studi
present
studi
also
shown
acth
product
increas
linearli
increas
concentr
lymphocyt
studi
harbour
et
al
establish
immun
system
process
pomc
product
differ
depend
stimulu
induct
exampl
b
lymphocyt
lpsresist
mice
express
process
pomc
lp
crf
treatment
b
cell
express
enzymat
activ
certain
ph
cleav
acth
smaller
studi
also
conclud
mice
resist
vivo
effect
lp
appear
express
enzym
necessari
process
pomc
molecul
lymphocyt
system
conclus
method
develop
acth
produc
human
lymphocyt
may
quantit
measur
studi
extend
investig
biolog
activ
neuropeptid
incub
lymphocyt
secret
acth
presenc
human
adren
fasciculata
cell
would
expect
cortisol
secret
cell
presenc
increas
